All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2007-D-0369
Industry Describing Product-Specific Bioequivalence Recommendations
Documents
2,062
Comments
32
Key Dates
Comment Period OpensMay 30, 2007
Comment Period ClosesJul 22, 2026
Documents
| Type | Title | Status |
|---|---|---|
Other |
Comment Statistics
Total Comments
32
Keywords
Specific Products
Product-Specific Bioequivalence
Draft Guidances
cder
open
Bioequivalence Recommendations for Risperidone
Xiaoqiu Tang
Risperdal Consta Long-Acting Injection
Data from Regulations.gov